ישראל -
עברית -
Ministry of Health
אנג'ריקס בי 10 מקג
glaxo smith kline (israel) ltd - purified hepatitis b antigen - תרחיף להזרקה - purified hepatitis b antigen 10 mcg / 0.5 ml - hepatitis b, purified antigen - hepatitis b, purified antigen - active immunization against hepatitis b virus infection.
ישראל -
עברית -
Ministry of Health
זוסטאווקס (zoster vaccine live)
merck sharp & dohme (israel - 1996) company ltd, israel - live attenuated oka/merck strain of varicella-zoster virus - אבקה וממס להכנת תרחיף להזרקה - live attenuated oka/merck strain of varicella-zoster virus 19400 pfu / 0.65 ml - zoster, live attenuated - zoster, live attenuated - zostavax is a live attenuated virus vaccine indicated for prevention of herpes zoster (shingles) in individuals 50 years of age and older.
ישראל -
עברית -
Ministry of Health
ריווטריל
tzamal bio-pharma ltd - clonazepam - טיפות - clonazepam 2.5 mg/ml - clonazepam - clonazepam - anti-epileptic. panic disorder.
ישראל -
עברית -
Ministry of Health
לורסטין סירופ
bayer israel ltd - loratadine - סירופ - loratadine 5 mg / 5 ml - loratadine - loratadine - antihistamine preparation for treatment of allergic rhinitis and urticaria.
ישראל -
עברית -
Ministry of Health
דספרל 0.5 גרם
novartis israel ltd - deferoxamine mesylate - אבקה להמסה להזרקה\אינפוזיה - deferoxamine mesylate 0.5 g/vial - deferoxamine - deferoxamine - treatment of chronic iron overload e.g.: transfusional haemosiderosis especially in thalassaemia major sideroblastic anaemia autoimmune haemolytic anaemia and other chronic anaemias idiopathic (primary) haemochromatosis in patients in whom concomitant disorders ( e.g. severe anaemia cardiac disease hypoproteinaemia) preclude phlebotomy iron overload associated with porphyria cutanea tarda. treatment of acute iron poisoning. treatment of chronic aluminium overload in patients with terminal renal failure (under maintenance dialysis) with: aluminium-related bone disease and/or dialysis encephalopathy and/or aluminium-related anaemia. diagnosis of iron overload.
ישראל -
עברית -
Ministry of Health
בוסטריקס פוליו
glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin (prn or 69 kda omp); pertussis toxoid vaccine; tetanus toxoid - תרחיף להזרקה - pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml; diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid vaccine 8 mcg / 0.5 ml; inactivated polio virus (ipv) type 3 32 du / 0.5 ml; inactivated polio virus (ipv) type 1 40 du / 0.5 ml; inactivated polio virus (ipv) type 2 8 du / 0.5 ml - bacterial and viral vaccines, combined - for booster vaccination against diphtheria, tetanus and pertusis and poliomyelitis of individuals from the age of four years onwards. boostrix polio is not intended for primary immunisation. the administration of boostrix polio should be based on official recommendations.
ישראל -
עברית -
Ministry of Health
שאוור פולישינג נאקטר פייץ בלוסום
תמר שיווק מוצרי בריאות טבעיים בעמ - ג'ל רחצה
ישראל -
עברית -
Ministry of Health
רצועות שעווה לפנים בניחוח אפרסק ומלון
אלפא חברה לקוסמטיקה בעמ - הסרת שיער מיותר מהפנים